- Home
- CMP vs SANA Comparison
CMP vs SANA Comparison
Compare CMP & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMP
- SANA
- Stock Information
- Founded
- CMP 1993
- SANA 2018
- Country
- CMP United States
- SANA United States
- Employees
- CMP N/A
- SANA N/A
- Industry
- CMP Other Metals and Minerals
- SANA Medicinal Chemicals and Botanical Products
- Sector
- CMP Basic Materials
- SANA Health Care
- Exchange
- CMP Nasdaq
- SANA Nasdaq
- Market Cap
- CMP 493.5M
- SANA 519.8M
- IPO Year
- CMP 2003
- SANA 2021
- Fundamental
- Price
- CMP $11.09
- SANA $1.58
- Analyst Decision
- CMP Buy
- SANA Strong Buy
- Analyst Count
- CMP 3
- SANA 5
- Target Price
- CMP $18.33
- SANA $9.50
- AVG Volume (30 Days)
- CMP 686.3K
- SANA 4.5M
- Earning Date
- CMP 05-06-2025
- SANA 05-07-2025
- Dividend Yield
- CMP N/A
- SANA N/A
- EPS Growth
- CMP N/A
- SANA N/A
- EPS
- CMP N/A
- SANA N/A
- Revenue
- CMP $1,082,900,000.00
- SANA N/A
- Revenue This Year
- CMP $4.89
- SANA N/A
- Revenue Next Year
- CMP $7.00
- SANA N/A
- P/E Ratio
- CMP N/A
- SANA N/A
- Revenue Growth
- CMP N/A
- SANA N/A
- 52 Week Low
- CMP $7.51
- SANA $1.26
- 52 Week High
- CMP $15.82
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- CMP 61.55
- SANA 40.76
- Support Level
- CMP $8.60
- SANA $1.32
- Resistance Level
- CMP $11.24
- SANA $1.92
- Average True Range (ATR)
- CMP 0.56
- SANA 0.22
- MACD
- CMP 0.25
- SANA 0.04
- Stochastic Oscillator
- CMP 91.48
- SANA 48.48
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.